Can-Fite BioPharma Ltd. Operating Lease Cost
Can-Fite BioPharma Ltd. (CANF) reported Operating Lease Cost of $53.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-26
| Period end | Operating Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $53.00K 20-F · filed 2026-03-26 |
| 2024-12-31 | $44.00K 20-F · filed 2026-03-26 |
| 2023-12-31 | $56.00K 20-F · filed 2026-03-26 |
| 2022-12-31 | $54.00K 20-F · filed 2024-03-28 |
| 2021-12-31 | $55.00K 20-F · filed 2023-03-30 |
| 2020-12-31 | $43.00K 20-F · filed 2022-03-24 |
| 2019-12-31 | $29.00K 20-F · filed 2021-03-25 |